PlainRecalls
FDA Drug Low Class III Terminated

Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.

Reported: July 26, 2023 Initiated: July 5, 2023 #D-0924-2023

Product Description

Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.

Reason for Recall

Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.

Details

Units Affected
20,884 cartons
Distribution
USA nationwide.
Location
Princeton, NJ

Frequently Asked Questions

What product was recalled?
Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.. Recalled by SUN PHARMACEUTICAL INDUSTRIES INC. Units affected: 20,884 cartons.
Why was this product recalled?
Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.
Which agency issued this recall?
This recall was issued by the FDA Drug on July 26, 2023. Severity: Low. Recall number: D-0924-2023.